In this issue:
Adding everolimus for first-line advanced breast cancer treatment
Cardioprotective strategy for nonmetastatic breast cancer on anthracyclines
Extended adjuvant letrozole in postmenopausal early-stage breast cancer
Trastuzumab for early-stage, HER2-positive breast cancer
Clinical and molecular characteristics of HER2-low-positive breast cancer
Physical activity and cognition before and after chemotherapy for breast cancer
Lifetime alcohol consumption trajectories and breast cancer risk
Outcomes of patients with metastatic breast cancer in phase 1 trials
Outcomes of breast cancer with low hormone receptor positivity
Association of metformin use with survival in surgically resected breast cancer
Please login below to download this issue (PDF)